

Although 55 percent of men are willing to carry the burden of contraception, no method exists between the two extremes: condoms (which fail an estimated 15 percent of the time) and vasectomy (an invasive procedure that’s difficult to reverse). Even less appealing may be the much-discussed male “pill,” still in clinical trials, which shuts down hormone production in the hypothalamus and requires monthly shots of testosterone to restore it. And although women have been using hormones to control fertility for years, less is known about the long-term effects of hormone disruption in men.
As an alternative, many of the new sperm stoppers that are in the works target the vas deferens, the tube along which sperm travel. The idea is to stop sperm at one localized site, rather than using hormones that can affect heart function, weight and cholesterol levels. Launch the gallery to see how they work.
Will the FDA clear deep-brain stimulation as a treatment for clinical depression by September 30, 2008?
Will the LHC be fully functional and producing data by October 31, 2008?

